Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer 2024 pay Source
Jeffrey Stein
President & CEO
Title from the Form 4 dated Jan 7, 2026
$5,965,903
Frank Karbe
Chief Financial Officer
Title from the Form 4 dated Jan 7, 2026
Not reported
Shane Ward
COO & CLO
Title from the Form 4 dated Jan 7, 2026
Not reported
Nicole Negar Davarpanah
Chief Medical Officer
Title from the Form 4 dated Jan 7, 2026
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 25, 2025 · updated by the 8-K of Jan 7, 2026

Directors
3
serving now
Director Source
Jon Filderman Joined Jan 7, 2026
Melissa Leonard Joined Jan 7, 2026
Dalton Smart Joined Jan 7, 2026

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

6 disclosed in the proxy filed Apr 25, 2025
Dr. Sandison
Amount not stated

Separation agreement with Dr. Sandison upon his separation from the Company

With Company Open in proxy
named executive officers and directors
named executive officers and directors
Amount not stated

Grants of stock options and RSUs to named executive officers and stock options to directors

With Company Open in proxy
Entities Affiliated with BVF Partners L.P.
then holder of more than 5% of our Common Stock, or entity affiliated with such holder
$ 20,000,000

Purchased 20,000 shares of Series A Preferred Stock in the April 2024 private placement

With Company Open in proxy
RA Capital Healthcare Fund, L.P.
then holder of more than 5% of our Common Stock, or entity affiliated with such holder
$ 25,000,000

Purchased 389,716 shares of Common Stock and 1,286,786 pre-funded warrants in the November 2024 private placement

With Company Open in proxy
Entities Affiliated with BVF Partners L.P.
then holder of more than 5% of our Common Stock, or entity affiliated with such holder
$ 10,000,000

Purchased 389,731 shares of Common Stock and 280,869 pre-funded warrants in the November 2024 private placement

With Company Open in proxy
directors and executive officers
directors and executive officers
Amount not stated

Separate indemnification agreements requiring the Company to indemnify directors and executive officers for certain expenses

With Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support